Ping Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ping Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,000	Closed	-$317K	–	97
2026 Q1	$317K	Buy	+12,000	New	+$351K	0.09%	74
2025 Q4	–	Sell	-15,000	Closed	-$417K	–	81
2025 Q3	$417K	Sell	15,000 -1,000	-6%	-$25.3K	0.14%	52
2025 Q2	$390K	Sell	16,000 -1,000	-6%	-$21.9K	0.09%	60
2025 Q1	$353K	Buy	17,000 +2,000	+13%	+$50.2K	0.13%	68
2024 Q4	$353K	Buy	15,000 +1,000	+7%	+$24.6K	0.09%	68
2024 Q3	$358K	Buy	14,000 +3,900	+39%	+$99.3K	0.1%	66
2024 Q2	$237K	Buy	+10,100	New	+$255K	0.07%	66

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

SFC

Strategic Financial Concepts San Antonio, Texas $336M AUM 22.98% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

Ping Capital Management's ARKG Position: Q2 2026 in Review

Ping Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 12,000 shares — an estimated $317K sold.

Ping Capital Management first reported a position in ARKG in Q2 2024 and held it in 7 quarters. The position peaked at $417K in Q3 2025. 106 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Ping Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Ping Capital Management sold 12,000 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $317K.
Ping Capital Management first reported a position in ARK Genomic Revolution ETF in Q2 2024 and held it in 7 quarters.
Ping Capital Management's ARK Genomic Revolution ETF position peaked at $417K in Q3 2025.
106 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Ping Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.